James David Pancook

This inventor holds 10 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Eli Lilly and Company, Elanco US Inc., Applied Molecular Evolution. Active years: 2006-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James David Pancook. Retrieved from https://idiyas.com/inventor/james-david-pancook

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 10 (Patent Applications = 3)

% Patents Active = 60.0

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 1.9

ph-index = 3

Forward Citations = 49(Granted Patents)

Location History:

San Diego, CA (US) (2006 - 2022)
Indianapolis, IN (US) (2022)

Company Filing History:

6 out of 4,517

Eli Lilly and Company

Applied Molecular Evolution

patents

Years Active: 2006-2025

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12195548 - Chimeric canine anti-CD20 antibody (2025-01-14),

2. 12145972 - Neuregulin-4 compounds and methods of use (2024-11-19),

3. 11466066 - Variants of human BMP7 protein (2022-10-11),

4. 11242370 - Neuregulin-4 compounds and methods of use (2022-02-08),

5. 10941206 - Chimeric canine anti-CD20 antibody (2021-03-09),

6. 10519244 - Chimeric canine anti-CD20 antibody (2019-12-31),

7. 7927593 - TGF-beta binding antibodies (2011-04-19),

8. 7494651 - TGF-β binding antibodies (2009-02-24),

9. 7049121 - Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use (2006-05-23),

10. 6989261 - Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use (2006-01-24),

Title: Innovations and Contributions of James David Pancook

Introduction

James David Pancook is a notable inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies and compounds. With a total of 10 patents to his name, Pancook's work has the potential to impact veterinary medicine and beyond.

Latest Patents

Among his latest patents is the "Chimeric canine anti-CD20 antibody," which relates to caninized chimeric anti-CD20 antibodies targeting the canine protein CD20. This invention offers methods of use to treat disorders such as non-Hodgkin's B-cell lymphoma in dogs. Another significant patent is for "Neuregulin-4 compounds and methods of use," which focuses on neuregulin (NRG) 4 compounds and their therapeutic applications.

Career Highlights

Pancook has worked with prominent companies in the pharmaceutical industry, including Eli Lilly and Company and Elanco US Inc. His experience in these organizations has contributed to his expertise in developing innovative solutions for medical challenges.

Collaborations

Throughout his career, Pancook has collaborated with talented individuals such as Scott William Rowlinson and Bryan Edward Jones. These partnerships have fostered a creative environment that has led to groundbreaking inventions.

Conclusion

James David Pancook's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in veterinary medicine and therapeutic treatments.

Profile summary based on public USPTO records.